Open access · OA
via OpenAlex
Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies
Mohammad Qadura, Daniella C. Terenzi, Subodh Verma, Mohammed Al-Omran, David A. Hess
Stem Cells · 2017 · ▲ 205 citations
Abstract
Critical limb ischemia (CLI), the most severe form of peripheral artery disease, is characterized by pain at rest and non-healing ulcers in the lower extremities. For patients with CLI, where the extent of atherosclerotic artery occlusion is too severe for surgical bypass or percutaneous interventions, limb amputation remains the only treatment option. Thus, cell-based therapy to restore perfusion and promote wound healing in patients with CLI is under intense investigation. Despite promising preclinical studies in animal models, transplantation of bone marrow (BM)-derived cell populations in patients with CLI has shown limited benefit preventing limb amputation. Early trials injected heterogenous mononuclear cells containing a low frequency of cells with pro-vascular regenerative functions. Most trials transferred autologous cells damaged by chronic disease that demonstrated poor survival in the ischemic environment and impaired function conferred by atherosclerotic or diabetic co-morbidities. Finally, recent preclinical studies suggest optimized blood vessel formation may require paracrine and/or structural contributions from multiple progenitor cell lineages, angiocrine-secretory myeloid cells derived from hematopoietic progenitor cells, tubule-forming endothelial cells generated by circulating or vessel-resident endothelial precursors, and vessel-stabilizing perivascular cells derived from mesenchymal stem cells. Understanding how stem cells co-ordinate the myriad of cells and signals required for stable revascularization remains the key to translating the potential of stem cells into curative therapies for CLI. Thus, combination delivery of multiple cell types within supportive bioengineered matricies may represent a new direction to improve cell therapy strategies for CLI. Stem Cells 2018;36:161-171.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/stem.2751
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Qadura, M., Terenzi, D.C., Verma, S., Al-Omran, M., & Hess, D.A. (2017). Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. <em>Stem Cells</em>. https://doi.org/10.1002/stem.2751
Vancouver
Qadura M, Terenzi DC, Verma S, Al-Omran M, Hess DA. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies. Stem Cells. 2017. doi:10.1002/stem.2751.
BibTeX
@article{mohammad2017Concis,
title = {Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies},
author = {Mohammad Qadura and Daniella C. Terenzi and Subodh Verma and Mohammed Al-Omran and David A. Hess},
journal = {Stem Cells},
year = {2017},
doi = {10.1002/stem.2751},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Expert Opinion on Biological Therapy 2023
Preprint · OA
Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
Cells 2022
Open access · CC-BY
Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
Cell Medicine 2018
Open access · CC-BY
The effect of age on stem cell function and utility for therapy
Frontiers in immunology 2025
Open access · OA
Natural killer cell-based senotherapy: a promising strategy for healthy aging.
World Journal of Experimental Medicine 2024
Open access · CC-BY
Anti-aging based on stem cell therapy: A scoping review
Circulation Research 2012
Open access · OA